DeepTek CXR Analyzer vs AVIEW

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

DeepTek CXR Analyzer

by DeepTek

AVIEW

by Coreline Soft Co.

AI Verdict

DeepTek CXR Analyzer is designed for AI-powered computer-assisted detection on chest X-rays, focusing on initial screening and workflow efficiency for lung, pleural, and cardiac pathologies. In contrast, AVIEW specializes in comprehensive AI analysis of CT scans for the early detection, diagnosis, and monitoring of conditions like lung cancer, COPD, and coronary artery calcification, offering detailed quantification and 3D visualizations. While both serve similar specialties, their distinct imaging modalities (CXR vs. CT) mean they address different stages and depths of diagnostic needs.

Choose DeepTek CXR Analyzer if…

Choose DeepTek CXR Analyzer if your primary need is to enhance the efficiency and accuracy of routine chest X-ray interpretations. This tool is ideal for high-volume settings where radiologists require AI-powered assistance for rapid detection and highlighting of common lung, pleural, and cardiac pathologies, significantly reducing workload and improving diagnostic throughput.

View DeepTek CXR Analyzer →

Choose AVIEW if…

Choose AVIEW if your focus is on comprehensive and detailed analysis of CT scans for specific conditions such as early lung cancer detection, COPD assessment, or coronary artery calcification. This platform excels in providing advanced quantification, 3D visualizations, and longitudinal tracking capabilities for complex pulmonary and cardiac pathologies identified via CT imaging.

View AVIEW →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	DeepTek CXR Analyzer	AVIEW
Pricing	Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription.	Subscription; one-off payment
Deployment	On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment.	Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker)
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AVIEW

AVIEW offers advanced features like 3D visualizations and comprehensive PDF reports, which enhance the user's ability to interpret and explain complex cases. Its recent AVIEW 2.0 upgrade also specifically highlights improvements in UI/UX, suggesting a strong focus on user experience. DeepTek CXR Analyzer, while emphasizing seamless PACS integration and intelligent scan segregation, does not detail the same level of advanced visualization or explicit UI/UX upgrades.

Clinical Value

AVIEW

AVIEW provides a broader and deeper range of clinical analyses from CT scans, covering multiple complex pathologies like lung cancer nodule characterization, emphysema quantification, coronary artery calcium scoring, and interstitial lung disease pattern analysis. DeepTek CXR Analyzer is highly effective for chest X-ray analysis, detecting 28 findings and demonstrating significant productivity gains, but AVIEW's multi-disease, multi-parameter approach on CT scans offers more comprehensive clinical utility.

Pricing & Value

AVIEW

While both tools offer flexible pricing models, AVIEW recently achieved a US billing code for its Coronary Artery Calcification (CAC) analysis, which significantly enhances its value proposition by facilitating reimbursement. DeepTek's 'contact sales' approach for its pay-per-use model, while flexible, offers less upfront pricing transparency. The ability to secure reimbursement for specific AI analyses provides a clear advantage in terms of value for healthcare providers.

Enterprise Readiness

AVIEW

Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and robust PACS integration. However, AVIEW offers broader deployment options, including dedicated hardware and virtualized solutions, in addition to cloud and hybrid. Furthermore, Coreline Soft explicitly mentions GDPR compliance and recent FDA clearance renewal based on strengthened cybersecurity criteria, indicating a comprehensive approach to enterprise-level security and deployment flexibility.

Innovation

AVIEW

AVIEW demonstrates greater innovation by offering an integrated diagnostic ecosystem that seamlessly combines lung cancer screening, COPD quantification, and coronary artery calcium scoring from a single CT scan. This represents a shift from task-specific tools to a more holistic analytical pipeline, including advanced quantification, 3D visualizations, and longitudinal tracking. DeepTek's CXR Analyzer is a valuable CADe solution for chest X-rays, but AVIEW's multi-disease, multi-parameter approach on CT scans showcases a more advanced and integrated application of AI.

Support & Docs

Tie

Both companies appear to offer documentation and support channels. DeepTek mentions a 'Resources Hub' with publications and white papers, along with specific installation guides. Coreline Soft lists a customer service email and provides various technical catalogs for its AVIEW products. Without specific details on the quality, responsiveness, or breadth of support and documentation, it is difficult to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	DeepTek CXR Analyzer	AVIEW
Product Name	DeepTek CXR Analyzer	AVIEW
Primary Imaging Modality	Chest X-ray (CXR)	CT scans
Key Pathologies/Findings Detected	Detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware; automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs).	AI-powered lung nodule detection and characterization; Emphysema quantification; Coronary artery calcium (CAC) scoring; Automated segmentation of lung lobes, airways, vessels, and coronary arteries; Interstitial Lung Disease (ILD) pattern analysis.
Workflow Integration	Seamless DICOM-based PACS integration (on-premise or cloud); Generates secondary capture DICOM with AI output.	Workflow automation and integration with PACS/RIS/CIS; Follow-up registration and nodule matching for serial CT scans.
Supported Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring DeepTek CXR Analyzer and AVIEW.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing radiology workflows, and what specific outputs do they generate to assist radiologists?

DeepTek CXR Analyzer integrates seamlessly with existing PACS, processing DICOM images in the background without altering current workflows. It then sends AI output, including intelligent segregation of scans and highlighted regions of interest with bounding boxes, back to PACS as secondary capture DICOM. AVIEW offers workflow automation and integration with PACS, RIS, and CIS, generating 3D visualizations and comprehensive PDF reports to streamline diagnostic processes.

What are the primary clinical applications and imaging modalities each tool is designed for, and how do their diagnostic focuses differ?

DeepTek CXR Analyzer is an AI-powered CADe solution specifically for chest X-ray analysis, detecting 28 findings across lung, pleural, and cardiac pathologies, as well as hardware. AVIEW is designed for CT scans, offering comprehensive solutions for early detection, diagnosis, and monitoring of lung cancer (nodule analysis, Lung-RADS), COPD (emphysema quantification), and coronary artery calcification (CAC scoring), alongside interstitial lung disease pattern analysis.

What is the expected impact on radiologist workload and productivity when using these AI solutions?

DeepTek CXR Analyzer is designed to significantly reduce radiologist workload by 30-50% and boost productivity by 2x-3x through its automated detection and intelligent segregation of chest X-ray scans. AVIEW aims to enhance diagnostic precision and streamline radiology workflows, contributing to time savings and reduced workload through features like automated nodule matching and comprehensive report generation.

What level of diagnostic detail and specificity do the AI outputs provide for identified pathologies?

DeepTek CXR Analyzer automatically identifies, categorizes, and highlights suspicious regions of interest (ROIs) across 28 findings in lung, pleural, and cardiac pathologies, as well as hardware, on chest X-rays. AVIEW provides detailed lung nodule detection and characterization, including size, volume, type, location, and Lung-RADS score, along with emphysema quantification and comprehensive coronary artery calcium scoring with risk stratification.

Do these solutions offer features that specifically aid in the long-term follow-up and monitoring of patients?

DeepTek's platform includes smart notifications that can remind patients of follow-up clinical exams after a predefined time interval, supporting long-term patient management. AVIEW offers features for follow-up registration and nodule matching for serial CT scans, automatically assessing growth and changes by measuring nodule volume and calculating volume doubling time.